6ehv
From Proteopedia
(Difference between revisions)
m (Protected "6ehv" [edit=sysop:move=sysop]) |
|||
| (One intermediate revision not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery== | |
| + | <StructureSection load='6ehv' size='340' side='right'caption='[[6ehv]], [[Resolution|resolution]] 2.54Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[6ehv]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6EHV OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6EHV FirstGlance]. <br> | ||
| + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6ehv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6ehv OCA], [http://pdbe.org/6ehv PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6ehv RCSB], [http://www.ebi.ac.uk/pdbsum/6ehv PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6ehv ProSAT]</span></td></tr> | ||
| + | </table> | ||
| - | + | ==See Also== | |
| - | + | *[[Antibody 3D structures|Antibody 3D structures]] | |
| - | + | *[[Monoclonal Antibodies 3D structures|Monoclonal Antibodies 3D structures]] | |
| - | [[Category: | + | __TOC__ |
| + | </StructureSection> | ||
| + | [[Category: Human]] | ||
| + | [[Category: Large Structures]] | ||
[[Category: Hargreaves, D]] | [[Category: Hargreaves, D]] | ||
| + | [[Category: Abvance]] | ||
| + | [[Category: Immune system]] | ||
| + | [[Category: Pistoia alliance]] | ||
| + | [[Category: Scfv]] | ||
Current revision
scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery
| |||||||||||
